Company intelligence / Profile preview

Lytical Ventures

New York, New York, United States

Ownership: Private
Development stage: Other

Overview

Lytical Ventures is a New York City-based venture capital firm rather than a drug developer, biotech operating company, or healthcare services provider. The firm focuses primarily on enterprise intelligence categories including cybersecurity, data analytics, and artificial intelligence. Publicly available descriptions indicate it invests in technology companies and has participated in some healthcare-related financings as an investor, but healthcare is not its core company identity. As such, it does not appear to have an internal therapeutic pipeline, clinical programs, or proprietary drug platform.

Industry: Investors

Beyond the preview

Go deeper on Lytical Ventures.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Lytical Ventures.

Explore the full profile